Literature DB >> 9774192

Comparison of the effects of ACE inhibition with those of angiotensin II receptor antagonism on systolic and diastolic myocardial stunning in isolated rabbit heart.

C Morales1, M Rodríguez, O Scapín, R J Gelpi.   

Abstract

The aim was to determine whether enalaprilat (0.08 mg/kg/min) or losartan (0.01 mg/kg/min) administration before ischemia can improve postischemic systolic and diastolic dysfunction ('stunned myocardium') and attenuate the 'hyperfunction' phase at the beginning of reperfusion. An isolated isovolumic rabbit heart preparation was subjected to 15 min of ischemia followed by 30 min of reperfusion without (group 1) or with pretreatment with enalaprilat (group 2) or losartan (group 3). Left ventricular developed pressure and end-diastolic pressure (diastolic stiffness) were measured and the time constant of isovolumic relaxation (T, Tau) and the ratio between +dP/dt and -dP/dt were calculated. In comparison to the stunned group (group 1) both enalaprilat (group 2) and losartan (group 3) exerted a significant protective effect on postischemic recovery of contractile state and diastolic stiffness. Only enalaprilat attenuated the 'hypercontractile' phase. However, both enalaprilat and losartan failed to improve myocardial relaxation. In summary, these data strongly suggest a direct deleterious action of the local renin-angiotensin system on ischemic myocardium and diminution of myocardial stunning with its successful blockade. Although, we can not exclude the possibility that bradykinin has some cardioprotective effect, these data suggest that angiotensin exacerbates myocardial injury.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9774192

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

1.  Biphasic changes in relaxation following reperfusion after myocardial ischemia.

Authors:  S M Mosca; M Carriquiriborde; H E Cingolani
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

2.  Effect of isoproterenol on relation between maximal rate of contraction and maximal rate of relaxation.

Authors:  A O de Gende; D P Alzueta; H E Cingolani
Journal:  Am J Physiol       Date:  1977-09

3.  Postischaemic hypercontraction is enhanced in ischaemically injured canine myocardium.

Authors:  T Yoshikawa; M Akaishi; F Ikeda; S Handa; Y Nakamura
Journal:  Cardiovasc Res       Date:  1992-04       Impact factor: 10.787

4.  The effects of Bay K 8644 on diastolic function in the dog heart.

Authors:  R J Gelpi; S M Mosca; H E Cingolani
Journal:  J Mol Cell Cardiol       Date:  1990-11       Impact factor: 5.000

5.  Effect of captopril on postischemic myocardial expansion.

Authors:  C Eng; B J Weil; E H Sonnenblick
Journal:  J Cardiovasc Pharmacol       Date:  1993-04       Impact factor: 3.105

6.  Intracoronary angiotensin-converting enzyme inhibition improves diastolic function in patients with hypertensive left ventricular hypertrophy.

Authors:  H L Haber; E R Powers; L W Gimple; C C Wu; K Subbiah; W H Johnson; M D Feldman
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

7.  Protection of the ischemic myocardium by the converting-enzyme inhibitor zofenopril: insight into its mechanism of action.

Authors:  R Ferrari; A Cargnoni; S Curello; C Ceconi; A Boraso; O Visioli
Journal:  J Cardiovasc Pharmacol       Date:  1992       Impact factor: 3.105

8.  Effect of a calcium-sensitizing positive inotropic agent MCI-154 and its combined use with enalapril on postischemic contractile dysfunction of dog hearts.

Authors:  Y Abe; Y Kitada; A Narimatsu
Journal:  J Cardiovasc Pharmacol       Date:  1995-10       Impact factor: 3.105

9.  Blockade by intravenous losartan of AT1 angiotensin II receptors in rat brain, kidney and adrenals demonstrated by in vitro autoradiography.

Authors:  J Zhuo; K Song; A Abdelrahman; F A Mendelsohn
Journal:  Clin Exp Pharmacol Physiol       Date:  1994-07       Impact factor: 2.557

10.  Influence of local converting enzyme inhibition on angiotensin and bradykinin effects in ischemic rat hearts.

Authors:  W Linz; B A Schölkens
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.